Bonnie L. Bassler, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 1,240 shares at $818.00 ($1.0M) on 2023-03-24, disclosed to the SEC on 2023-03-27.
Scheduled sale ($1.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| REGN | SELL | 2024-08-19 | $885K | — | Filing → |
| REGN | SELL | 2024-08-05 | $843K | — | Filing → |
| REGN | SELL | 2024-06-25 | $803K | — | Filing → |